Picture of Solventum logo

SOLV Solventum Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Solventum, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,4601,3431,3464791,556
Depreciation
Deferred Taxes
Non-Cash Items11210124146-1,326
Unusual Items
Other Non-Cash Items
Changes in Working Capital67-202126160-230
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,2021,6791,9151,185369
Capital Expenditures-277-251-290-380-379
Purchase of Fixed Assets
Other Investing Cash Flow Items-1-26003,176
Acquisition of Business
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-278-253-230-3802,797
Financing Cash Flow Items-1,960-1,460-1,552-8,24313
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,960-1,460-1,552-240-3,057
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-33-30133568116